These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30767895)

  • 21. Features of BSCL2 related congenital generalized lipodystrophy in China: long-term follow-up of three patients and literature review.
    Su X; Lin Y; Liu L; Mei H; Xu A; Zeng C; Sheng H; Cheng J; Shao Y; Zheng R; Ting TH; Zhang W; Li X
    J Pediatr Endocrinol Metab; 2023 Jan; 36(1):74-80. PubMed ID: 36433712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.
    Antuna-Puente B; Boutet E; Vigouroux C; Lascols O; Slama L; Caron-Debarle M; Khallouf E; Lévy-Marchal C; Capeau J; Bastard JP; Magré J
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1463-8. PubMed ID: 20097706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focus on progressive myoclonic epilepsy in Berardinelli-Seip syndrome.
    Sánchez-Iglesias S; Fernández-Pombo A; Araújo-Vilar D
    Neurol Sci; 2021 Apr; 42(4):1597-1598. PubMed ID: 33089476
    [No Abstract]   [Full Text] [Related]  

  • 24. Berardinelli-Seip congenital lipodystrophy.
    Mandal K; Aneja S; Seth A; Khan A
    Indian Pediatr; 2006 May; 43(5):440-5. PubMed ID: 16735770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations.
    Rubboli G; Franceschetti S; Berkovic SF; Canafoglia L; Gambardella A; Dibbens LM; Riguzzi P; Campieri C; Magaudda A; Tassinari CA; Michelucci R
    Epilepsia; 2011 Dec; 52(12):2356-63. PubMed ID: 22050460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation.
    Boissé Lomax L; Bayly MA; Hjalgrim H; Møller RS; Vlaar AM; Aaberg KM; Marquardt I; Gandolfo LC; Willemsen M; Kamsteeg EJ; O'Sullivan JD; Korenke GC; Bloem BR; de Coo IF; Verhagen JM; Said I; Prescott T; Stray-Pedersen A; Rasmussen M; Vears DF; Lehesjoki AE; Corbett MA; Bahlo M; Gecz J; Dibbens LM; Berkovic SF
    Brain; 2013 Apr; 136(Pt 4):1146-54. PubMed ID: 23449775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
    Nascimento FA; Andrade DM
    Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seipin ablation in mice results in severe generalized lipodystrophy.
    Cui X; Wang Y; Tang Y; Liu Y; Zhao L; Deng J; Xu G; Peng X; Ju S; Liu G; Yang H
    Hum Mol Genet; 2011 Aug; 20(15):3022-30. PubMed ID: 21551454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and electrophysiological features in a French family presenting with seipinopathy.
    Ollivier Y; Magot A; Latour P; Perrier J; Mercier S; Maisonobe T; Péréon Y
    Neuromuscul Disord; 2015 Feb; 25(2):161-4. PubMed ID: 25454168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new seipin-associated neurodegenerative syndrome.
    Guillén-Navarro E; Sánchez-Iglesias S; Domingo-Jiménez R; Victoria B; Ruiz-Riquelme A; Rábano A; Loidi L; Beiras A; González-Méndez B; Ramos A; López-González V; Ballesta-Martínez MJ; Garrido-Pumar M; Aguiar P; Ruibal A; Requena JR; Araújo-Vilar D
    J Med Genet; 2013 Jun; 50(6):401-9. PubMed ID: 23564749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complementary mutations in seipin gene in a patient with Berardinelli-Seip congenital lipodystrophy and dystonia: phenotype variability suggests multiple roles of seipin gene.
    Wu YR; Hung SI; Chang YC; Chen ST; Lin YL; Chung WH
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1180-1. PubMed ID: 19762912
    [No Abstract]   [Full Text] [Related]  

  • 32. Berardinelli-Seip syndrome in peritoneal dialysis.
    Bande-Fernández JJ; García-Castro R; Sánchez-Alvarez JE; Rodríguez-Suárez C; Coronel-Aguilar D; Hidalgo C; Istanbuli B; Merino-Bueno C; Del Rio-García L
    Nefrologia; 2015; 35(5):493-6. PubMed ID: 26391816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Talon cusps, macrodontia, and aberrant tooth morphology in Berardinelli-Seip syndrome.
    Solanki M; Patil SS; Baweja DK; Noorani H; Pk S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e41-7. PubMed ID: 18155601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exome sequencing circumvents missing clinical data and identifies a BSCL2 mutation in congenital lipodystrophy.
    Schuster J; Khan TN; Tariq M; Shaiq PA; Mäbert K; Baig SM; Klar J
    BMC Med Genet; 2014 Jun; 15():71. PubMed ID: 24961962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations in ASAH1.
    Rubboli G; Veggiotti P; Pini A; Berardinelli A; Cantalupo G; Bertini E; Tiziano FD; D'Amico A; Piazza E; Abiusi E; Fiori S; Pasini E; Darra F; Gobbi G; Michelucci R
    Epilepsia; 2015 May; 56(5):692-8. PubMed ID: 25847462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.
    Magré J; Delépine M; Khallouf E; Gedde-Dahl T; Van Maldergem L; Sobel E; Papp J; Meier M; Mégarbané A; Bachy A; Verloes A; d'Abronzo FH; Seemanova E; Assan R; Baudic N; Bourut C; Czernichow P; Huet F; Grigorescu F; de Kerdanet M; Lacombe D; Labrune P; Lanza M; Loret H; Matsuda F; Navarro J; Nivelon-Chevalier A; Polak M; Robert JJ; Tric P; Tubiana-Rufi N; Vigouroux C; Weissenbach J; Savasta S; Maassen JA; Trygstad O; Bogalho P; Freitas P; Medina JL; Bonnicci F; Joffe BI; Loyson G; Panz VR; Raal FJ; O'Rahilly S; Stephenson T; Kahn CR; Lathrop M; Capeau J;
    Nat Genet; 2001 Aug; 28(4):365-70. PubMed ID: 11479539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive myoclonus epilepsy without renal failure in a Chinese family with a novel mutation in SCARB2 gene and literature review.
    Tian WT; Liu XL; Xu YQ; Huang XJ; Zhou HY; Wang Y; Tang HD; Chen SD; Luan XH; Cao L
    Seizure; 2018 Apr; 57():80-86. PubMed ID: 29605618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic heterogeneity in biochemical parameters correlates with mutations in AGPAT2 or Seipin genes among Berardinelli-Seip congenital lipodystrophy patients.
    Gomes KB; Pardini VC; Ferreira AC; Fernandes AP
    J Inherit Metab Dis; 2005; 28(6):1123-31. PubMed ID: 16435205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of congenital generalized lipodystrophy (CGL) caused by BSCL2 gene mutation.
    Ye JY; Huang AJ; Fu ZZ; Gong YY; Yang HY; Zhou HW
    Yi Chuan; 2022 Oct; 44(10):926-936. PubMed ID: 36384728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
    Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
    Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.